Search Results - Schwarzbich, M.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

    Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma by Lisenko, K, McClanahan, F, Schöning, T, Schwarzbich, M A, Cremer, M, Dittrich, T, Ho, A D, Witzens-Harig, M

    Published in BMC cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma

    The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma by Madle, M., Krämer, I., Lehners, N., Schwarzbich, M., Wuchter, P., Herfarth, K., Egerer, G., Ho, A.D., Witzens-Harig, M.

    Published in Annals of hematology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    PS1135 MONOCYTIC BUT NOT GRANULOCYTIC MDSCS INCREASE WITH IBRUTINIB BUT NOT ACALABRUTINIB TREATMENT IN EM‐TCL1 MICE WITH CLL, SUGGESTING A ROLE FOR ITK INHIBITION IN MONOCYTIC MDSCS

    PS1135 MONOCYTIC BUT NOT GRANULOCYTIC MDSCS INCREASE WITH IBRUTINIB BUT NOT ACALABRUTINIB TREATMENT IN EM‐TCL1 MICE WITH CLL, SUGGESTING A ROLE FOR ITK INHIBITION IN MONOCYTIC MDSC... by Romero‐Toledo, A., Schwarzbich, M., Sanderson, R., Gribben, J.

    Published in HemaSphere
    Request full text
    Article
    Save to List
    Saved in:
  4. 4
    The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors

    The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors by Schwarzbich, Mark-Alexander, Gutknecht, Michael, Salih, Julia, Salih, Helmut R., Brossart, Peter, Rittig, Susanne M., Grünebach, Frank

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Immunosuppressive Drugs up-Regulate the Immunoinhibitory Receptor Osteoactivin On Human Monocyte-Derived Dendritic Cells

    Immunosuppressive Drugs up-Regulate the Immunoinhibitory Receptor Osteoactivin On Human Monocyte-Derived Dendritic Cells by Braun, Sabine, Gutknecht, Michael, Schwarzbich, Mark-Alexander, Kanz, Lothar, Salih, Helmut R, Grünebach, Frank, Rittig, Susanne M

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    The Immune-Inhibitory Receptor Osteoactivin Is up-Regulated In Monocyte-Derived Dendritic Cells Upon Exposure to Tyrosine Kinase Inhibitors

    The Immune-Inhibitory Receptor Osteoactivin Is up-Regulated In Monocyte-Derived Dendritic Cells Upon Exposure to Tyrosine Kinase Inhibitors by Gutknecht, Michael, Schwarzbich, Mark-Alexander, Salih, Julia, Kanz, Lothar, Salih, Helmut R., Schmidt, Susanne M., Grünebach, Frank

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: